LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients

BIOMEDICINES

Butova, R; Vychytilova-Faltejskova, P; Gregorova, J; Radova, L; Almasi, M; Bezdekova, R; Brozova, L; Jarkovsky, J; Knechtova, Z; Stork, M; Pour, L; Sevcikova, S, 2021: LncRNAs LY86-AS1 and VIM-AS1 Distinguish Plasma Cell Leukemia Patients from Multiple Myeloma Patients. BIOMEDICINES 9(11), doi: 10.3390/biomedicines9111637

Research Groups:

Molecular Oncology - Solid Cancer

CEITEC authors:

Petra Vychytilová, Ph.D.
Lenka Radová, Ph.D.